News & Trends - MedTech & Diagnostics
Australian-first health economic evaluation in lung cancer
MedTech & Diagnostics: Grampians Health has been selected to undertake an Australian-first health economic evaluation using digital tools to further optimise the care pathway for patients diagnosed with lung cancer.
Dubbed the ‘Simfonia’ project, it will be conducted in collaboration with Roche Diagnostics and is part of a global project that aims to further optimise how lung cancer care is delivered across communities.
Grampians Health is the second international site to go live after a successful project launch in Barcelona completed in 2023. This project’s necessity is underscored by local health data revealing that the Grampians region has a higher incidence of lung cancer than the state average in Victoria.
“We are committed to providing quality care to our regional communities. The Simfonia project will help us unlock more value from our existing resources to further enhance care delivery for patients with lung cancer and will add on to our ongoing efforts to provide world-class lung cancer care across regional Victoria,” said Dr Rob Grenfell, Chief Strategy and Regions Officer at Grampians Health.
Grampians Health is already demonstrating innovation and excellence in lung cancer care under Dr Wasek Faisal’s leadership and through the Rapid Access Lung Lesion Clinic (RALLC), where a multidisciplinary team of specialists from Oncology, Surgery and Respiratory Medicine are collaborating locally to provide streamlined and timely care at a local level.
Anticipated outcomes from Simfonia include optimising the patient pathway, improving the integration of services, maximising the use of diagnostic and care delivery resources and reviewing opportunities for new processes, technologies, and services.
“Roche has a global reputation for innovation. We believe this type of collaboration generates real world insights and strengthens our customers’ capability to optimise their health systems capacity and quality. This will directly benefit healthcare professionals and patients alike,” John Purdy, Global Healthcare Transformation Lead Consultant, Roche Diagnostics.
While the Simfonia project focuses on lung cancer care pathways, its approach could be extended to establish integrated healthcare services for other disease areas across the Australian healthcare system.
Improvements to lung cancer pathways will also ensure that Grampians Health is aligned with the new National Lung Cancer Screening Program. Screening services will begin for eligible people from July 2025, using low-dose computed tomography scans to look for lung cancer in high-risk people without any symptoms.
“Being selected for an opportunity like Simfonia allows Grampians Health to continue supporting timely innovation within the healthcare system, leading to more advanced patient care,” Dr Grenfell said.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Federal Health Minister succumbs to pressure, commits to extra meeting to clear PBAC backlog
Pharma News: The Minister for Health and Aged Care, Mark Butler MP, has confirmed that the Pharmaceutical Benefits Advisory Committee […]
MoreNews & Trends - MedTech & Diagnostics
Medtech company partners with Aussie researchers in AI technology for GI cancer detection
MedTech & Diagnostics News: To develop a next-generation gastrointestinal (GI) flexible endomicroscope equipped with edge-artificial intelligence (AI) technology, Monash University’s […]
MoreNews & Trends - Pharmaceuticals
Local oncologists first to enrol prostate cancer patients in phase 3 theranostics trial
Pharma News: GenesisCare oncologists have achieved a significant milestone, becoming the first to enrol and deliver patient treatment in a […]
MoreHuman Resources
Ipsen’s culture of ‘collaboration and diversity’ earns Great Place to Work certification
Ipsen Australia and New Zealand has announced its certification as a Great Place to Work in 2024, joining 11 other […]
More